Mutual of America Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Mutual of America Capital Management's NEO Position: Q2 2026 in Review
Mutual of America Capital Management increased its NeoGenomics (NEO) stake by 0.72% in Q2 2026, buying an estimated $1.02K and bringing the position to 14,913 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1385.
Mutual of America Capital Management first reported a position in NEO in Q1 2019 and has held it in 30 quarters since. The position peaked at $6.36M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Mutual of America Capital Management held 14,913 shares of NeoGenomics worth $218K as of Q2 2026.
- Mutual of America Capital Management bought 106 NeoGenomics shares in Q2 2026, an estimated $1.02K.
- NeoGenomics made up ﹤0.01% of Mutual of America Capital Management's portfolio in Q2 2026, its #1385 holding.
- Mutual of America Capital Management first reported a position in NeoGenomics in Q1 2019 and has held it in 30 quarters since.
- Mutual of America Capital Management's NeoGenomics position peaked at $6.36M in Q4 2020.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.